MicrofluidX

Startup

MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy. Its automated, closed bioprocessing platforms allows scientists to easily carry out process development by running dozens of cell culture conditions in parallel with extreme process control, and to scale up seamlessly up to several billion cells for patient dose manufacturing at a fraction of the current costs.



website


Get involved with Advanced Therapies Congress

 

To speak


Jessica Robinson
Jessica.Robinson@terrapinn.com
+44 208 164 3086

 

 

To sponsor or exhibit


Ashlea Foster
Ashlea.Foster@terrapinn.com
+44 208 164 3032